Evidence map›Paper›PMID 31653783›Full record

ArticleJournal of the American Society of Nephrology : JASN2019

Integrin-Linked Kinase Deficiency in Collecting Duct Principal Cell Promotes Necroptosis of Principal Cell and Contributes to Kidney Inflammation and Fibrosis.

Ming Huang, Shuai Zhu, Huihui Huang, Jinzhao He, Kenji Tsuji, William W Jin, Dongping Xie, Onju Ham, Diane E Capen, Weining Lu and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Integrins in the kidney - beyond the matrix.Nature reviews. Nephrology · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Vitamin A and retinoid signaling in the kidneys.Pharmacology & therapeutics · 2023
    Review
  10. Review
  11. Article
  12. Genes · 2023
    Article
  13. Article
  14. Integrin-linked kinase (ILK): the known vs. the unknown and perspectives.Cellular and molecular life sciences : CMLS · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Frontiers in pharmacology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Ming HuangDepartment of Pharmacology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Shuai ZhuDepartment of Pharmacology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Huihui HuangCenter for Systems Biology, Program in Membrane Biology, Division of Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Jinzhao HeDepartment of Pharmacology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Kenji TsujiCenter for Systems Biology, Program in Membrane Biology, Division of Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
William W JinCenter for Systems Biology, Program in Membrane Biology, Division of Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Dongping XieDepartment of Physiology, Tongji University School of Medicine, Shanghai, China; and.
Onju HamCenter for Systems Biology, Program in Membrane Biology, Division of Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Diane E CapenCenter for Systems Biology, Program in Membrane Biology, Division of Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Weining LuRenal Section, Departments of Medicine, and Pathology & Laboratory Medicine, Boston University Medical Center, Boston, Massachusetts.
Teodor G PăunescuCenter for Systems Biology, Program in Membrane Biology, Division of Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Baoxue YangDepartment of Pharmacology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China; Lu.Hua@mgh.harvard.edu baoxue@bjmu.edu.cn.
Hua A Jenny LuCenter for Systems Biology, Program in Membrane Biology, Division of Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Lu.Hua@mgh.harvard.edu baoxue@bjmu.edu.cn.
Center for Systems Biology · USMassachusetts General Hospital · USPeking University · CNBoston Medical Center · USHarvard University · USTongji University · CN

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Ramnik J Xavier · 1991 to 2026
$35.3M
Transgenic CoreP30DK057521 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, DENNIS · 2000 to 2019
$31.4M
SIGNALLING IN MESANGIAL CELLS--CALCIUM AND PHOPHOLIPASESP01DK038452 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BROWN, DENNIS · 1987 to 2012
$20.1M
Novel roles of integrin b1 signaling in regulating principal cell function andmaintaining collecting duct integrityR01DK096015 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI LU, HUA A · 2013 to 2022
$3.7M
Molecular Pathogenesis of Vesicoureteral RefluxR01DK078226 · NIDDK · BOSTON MEDICAL CENTER · PI LU, WEINING · 2008 to 2018
$2.5M
New Therapeutic Leads for Proteinuric Kidney DiseasesR01DK133940 · NIDDK · BOSTON MEDICAL CENTER · PI LU, WEINING · 2022 to 2024
$790k
Role of the novel gene fam4b in phosphatidylserine synthesis in podocytes and maiR21DK092619 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI LU, HUA A · 2012 to 2012
$257k
NIDDK NIH HHS P01 DK038452NIDDK NIH HHS P30 DK043351NIDDK NIH HHS P30 DK057521NIDDK NIH HHS R01 DK078226NIDDK NIH HHS R01 DK096015NIDDK NIH HHS R01 DK133940NIDDK NIH HHS R21 DK092619
6 · The paper itself

Abstract

backgroundNecroptosis is a newly discovered cell death pathway that plays a critical role in AKI. The involvement of integrin-linked kinase (ILK) in necroptosis has not been studied.

methodsWe performed experiments in mice with an

results

conclusionsThe study demonstrates the critical involvement of ILK in necroptosis through modulation of the RIPK3 and MLKL pathway and highlights the contribution of CD PC injury to the development of inflammation and interstitial fibrosis of the kidney.

Indexed as

NecroptosisAnimalsCells, CulturedFibrosisKidneyKidney Tubules, CollectingMiceMice, Inbred C57BLNephritisProtein KinasesProtein Serine-Threonine KinasesReceptor-Interacting Protein Serine-Threonine KinasesScaffold Protein ILKSmad ProteinsTransforming Growth Factor betaMLKL protein, mouseProtein KinasesProtein Serine-Threonine KinasesReceptor-Interacting Protein Serine-Threonine KinasesRipk3 protein, mouseScaffold Protein ILKSmad ProteinsTransforming Growth Factor betacollecting duct principal cellsintegrin-linked kinase (ILK)necroptosis

Identifiers

PMID31653783
PMCPMC6830785
OpenAlexW2981884188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.